BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3117701)

  • 1. Selective procedure to isolate haemophilus influenzae from sputa with large quantities of Pseudomonas aeruginosa.
    Bauernfeind A; Rotter K; Weisslein-Pfister C
    Infection; 1987; 15(4):278-80. PubMed ID: 3117701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis.
    Bauernfeind A; Bertele RM; Harms K; Hörl G; Jungwirth R; Petermüller C; Przyklenk B; Weisslein-Pfister C
    Infection; 1987; 15(4):270-7. PubMed ID: 3117700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyocin typing of Pseudomonas aeruginosa.
    Farmer JJ; Herman LG
    J Infect Dis; 1974 Nov; 130 Suppl(0):S43-6. PubMed ID: 4213993
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification and functional analysis of a bacteriocin, pyocin S6, with ribonuclease activity from a Pseudomonas aeruginosa cystic fibrosis clinical isolate.
    Dingemans J; Ghequire MG; Craggs M; De Mot R; Cornelis P
    Microbiologyopen; 2016 Jun; 5(3):413-23. PubMed ID: 26860427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective media for the quantitation of bacteria in cystic fibrosis sputum.
    Wong K; Roberts MC; Owens L; Fife M; Smith AL
    J Med Microbiol; 1984 Apr; 17(2):113-9. PubMed ID: 6423825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogenous Susceptibility to R-Pyocins in Populations of Pseudomonas aeruginosa Sourced from Cystic Fibrosis Lungs.
    Mei M; Thomas J; Diggle SP
    mBio; 2021 May; 12(3):. PubMed ID: 33947755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patients.
    van Belkum A; Renders NH; Smith S; Overbeek SE; Verbrugh HA
    FEMS Immunol Med Microbiol; 2000 Jan; 27(1):51-7. PubMed ID: 10617790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and risk of cross-colonization in cystic fibrosis holiday camps.
    Hoogkamp-Korstanje JA; van der Laag J
    Antonie Van Leeuwenhoek; 1980; 46(1):100-1. PubMed ID: 6772098
    [No Abstract]   [Full Text] [Related]  

  • 9. Pyocin-sensitivity testing as a method of typing Pseudomonas aeruginosa: use of "phage-free" preparations of pyocin.
    Rampling A; Whitby JL; Wildy P
    J Med Microbiol; 1975 Nov; 8(4):531-41. PubMed ID: 812999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of pyocin S2 against Pseudomonas aeruginosa biofilms.
    Smith K; Martin L; Rinaldi A; Rajendran R; Ramage G; Walker D
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1599-601. PubMed ID: 22183174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemophilus influenzae is frequently detected with monoclonal antibody 8BD9 in sputum samples from patients with cystic fibrosis.
    Möller LV; Ruijs GJ; Heijerman HG; Dankert J; van Alphen L
    J Clin Microbiol; 1992 Sep; 30(9):2495-7. PubMed ID: 1401024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyocin sensitivity of pseudomonas aeruginosa pretreated with antibiotics.
    Stevens GS; Ottolenghi AC
    Can J Microbiol; 1977 May; 23(5):583-8. PubMed ID: 194663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemophilus infections in cystic fibrosis.
    George RH; Gillett AP; Roycroft CA
    Lancet; 1980 Aug; 2(8188):262. PubMed ID: 6105423
    [No Abstract]   [Full Text] [Related]  

  • 14. Metagenome - Inferred bacterial replication rates in cystic fibrosis airways.
    Pienkowska K; Wiehlmann L; Tümmler B
    J Cyst Fibros; 2019 Sep; 18(5):653-656. PubMed ID: 30685331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acetyl-D-glucosamine medium improves recovery of Haemophilus influenzae from sputa of patients with cystic fibrosis.
    Möller LV; van Alphen L; Grasselier H; Dankert J
    J Clin Microbiol; 1993 Jul; 31(7):1952-4. PubMed ID: 7688756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotypes and antibiotic susceptibilities of Pseudomonas aeruginosa isolates from single sputa of cystic fibrosis patients.
    Seale TW; Thirkill H; Tarpay M; Flux M; Rennert OM
    J Clin Microbiol; 1979 Jan; 9(1):72-8. PubMed ID: 107186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced sputum compared to bronchoalveolar lavage in young, non-expectorating cystic fibrosis children.
    Blau H; Linnane B; Carzino R; Tannenbaum EL; Skoric B; Robinson PJ; Robertson C; Ranganathan SC
    J Cyst Fibros; 2014 Jan; 13(1):106-10. PubMed ID: 23806622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sputum bacteriology in patients with cystic fibrosis in a Toronto hospital during 1970-1981.
    Corey M; Allison L; Prober C; Levison H
    J Infect Dis; 1984 Feb; 149(2):283. PubMed ID: 6421945
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidence of common pyocin types of Pseudomonas aeruginosa from patients with cystic fibrosis and chronic airways diseases.
    Tredgett MW; Doherty C; Govan JR
    J Med Microbiol; 1990 Jul; 32(3):169-72. PubMed ID: 2115590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro pyocin activity of Pseudomonas aeruginosa strains pretreated with antibiotics.
    Al-Ani FY; Al-Shibib AS
    Folia Microbiol (Praha); 1985; 30(4):349-52. PubMed ID: 3928466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.